Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
03/2010
03/18/2010US20100068698 Production of infectious hepatitis c virus particles in cell culture
03/18/2010US20100068225 Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof
03/18/2010US20100068218 Optimized Multi-Epitope Constructs and Uses Thereof
03/18/2010US20100068183 Methods of treating lysosomal storage related diseases by gene therapy
03/17/2010EP2163260A2 Chimpanzee adenovirus vaccine carriers
03/17/2010EP2162745A1 New mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance
03/17/2010EP1556493B1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
03/17/2010EP0833923B2 Immunogenic construct, process for its preparation and use as a vaccine
03/17/2010CN101671656A Method for targeting and killing prostate tumor cells by oncolytic I type herpes simplex viruses
03/17/2010CN101670101A Attenuated live vaccine
03/16/2010US7678569 Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof
03/16/2010US7678538 Disinfection of biological fluids using asymmetric cyanine dyes
03/16/2010US7678376 Recombinant parainfluenza virus expression systems and vaccines
03/16/2010US7678374 Viral vectors expressing fusion of viral large envelope protein and protein of interest
03/16/2010CA2340422C Method for producing yeast expressed hpv types 6 and 16 capsid proteins
03/11/2010WO2010026965A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells
03/11/2010WO2009140326A3 Microfluidic isolation of tumor cells or other rare cells from whole blood or other liquids
03/11/2010WO2009136977A3 Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof
03/11/2010WO2009120883A3 Virus-like particle mediated cellular delivery
03/11/2010US20100062524 Methods and compositions relating to improved lentiviral vector production systems
03/11/2010US20100062489 Duck embryonic derived stem cell lines for the production of viral vaccines
03/11/2010US20100062421 Compositions, methods, and devices for isolating biological materials
03/11/2010US20100062419 Infectious, Chimeric Hepatitis C Virus, Methods of Producing the Same and Methods of Use Thereof
03/11/2010US20100062418 Inactivated and dried biological preparations
03/11/2010US20100062417 Zeolite crystals with biological material
03/11/2010US20100062020 Method of Treating a Malignancy in a Subject Via Direct Picornaviral-Mediated Oncolysis
03/11/2010US20100062016 Microorganisms for therapy
03/11/2010US20100061977 Methods and compositions for treating and diagnosing diseases
03/09/2010US7674621 Lambda phages useful in introducing recombineering functions into host cells; origin of replication (ori) selected from pSC101, colE1, pBBR1 and RK2
03/09/2010US7674612 Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof
03/09/2010US7674468 Herpes simplex virus (HSV) comprising deletion, insertion, or substitution in each gamma 34.5 gene; lysis
03/09/2010US7674467 Using pulsed field gel electrophoresis (PFGE) as diagnostic patterning tool for detection of bacterial infection
03/09/2010CA2308904C Process for the inactivation of viruses
03/09/2010CA2156007C Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions
03/04/2010WO2010006296A3 New avian bornavirus
03/04/2010WO2010003691A3 BIOCONJUGATES COMPRISING Aβ-AUTOANTIBODY SPECIFIC EPITOPES FOR ACTIVE IMMUNOTHERAPY AND DIAGNOSIS OF ALZHEIMER'S DISEASE
03/04/2010US20100055763 Method for the production and purification of retroviral vectors
03/04/2010US20100055670 Growth of wild-type hepatitis a virus in cell culture
03/04/2010US20100055669 Generation of Recombinant Genes in Bacteriophages
03/04/2010US20100055131 Reovirus compositions and methods of use
03/04/2010US20100055128 Method for the purification of alphavirus replicon particles
03/04/2010US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
03/04/2010US20100055121 Brachyury polypeptides and methods for use
03/04/2010US20100055105 Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof
03/03/2010EP1642966B1 Minus strand rna viral vectors carrying a gene with altered hypermutable regions
03/03/2010EP0973381B1 Animal model for evaluation of vaccines
03/03/2010EP0859831B1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences
03/03/2010CN101659942A Swine mycoplasma hyopneumoniae p52 gene recombinant adenovirus and construction method and application thereof
03/03/2010CN101658669A Attenuated live vaccine
03/02/2010US7671250 Mammal that has acquired immunological tolerance to a foreign DNA and/or its expression product; expresses a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes
03/02/2010US7670837 Non-tumorigenic MDCK cell line for propagating viruses
03/02/2010US7670801 Using immunoglobulins to isolate heterologous polypeptide fusion comprising viral coat sequences in adenoviral protein expression systems of plants, animals and bacteria
03/02/2010US7670598 Method for limiting the growth of cancer cells using an attenuated measles virus
02/2010
02/25/2010WO2009151697A3 Compositions and processes relating to human bocavirus
02/25/2010WO2009146210A3 New human parvovirus: bocavirus
02/25/2010WO2009126308A3 Compositions and methods for vaccine and virus production
02/25/2010US20100048683 Modified vaccinia virus ankara for the vaccination of neonates
02/25/2010US20100047897 Process for producing modified reconstituted sendai viral envelope specific for drug and/or gene delivery to liver cells
02/25/2010US20100047896 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle
02/25/2010US20100047895 Methods for purification of bacterial cells and cell components
02/25/2010US20100047327 Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
02/25/2010US20100047281 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
02/25/2010US20100047278 Human Rotavirus and Vaccine Composition Comprising Same
02/25/2010US20100047264 Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof
02/25/2010US20100047208 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
02/25/2010DE202009002058U1 Lebendimpfstoffzusammensetzung Live vaccine composition
02/24/2010EP2157173A1 An avian embryo particulate biomass for the production of virus antigens
02/24/2010EP2155246A1 Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
02/24/2010CN101653602A Treatment, prophylaxis and diagnostic reagent of hepatitis b
02/24/2010CN100591769C Regulated nucleic acid expression system
02/24/2010CN100591759C Animal protein free media for cultivation of cells
02/23/2010US7667092 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
02/23/2010US7666654 Method for preparing viral material
02/23/2010US7666610 Expressing transporters on viral envelopes
02/23/2010US7666434 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides
02/23/2010US7666433 Recombinant RSV strains with altered G protein
02/23/2010US7666408 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage
02/23/2010US7666405 Deleted adenovirus vectors and methods of making and administering the same
02/18/2010WO2010019572A1 Compositions and methods for the production of alpha-herpesviruses
02/18/2010WO2010019480A1 Attenuated herpesviruses encoding a mek pathway polypeptide
02/18/2010WO2010017819A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a
02/18/2010WO2010017818A1 Efficient cell culture system for hepatitis c virus genotype 2b
02/18/2010WO2009037402A9 Hpiv-2 variants and medical applications thereof
02/18/2010US20100041614 Metastasis-specific peptides and their diagnostic and therapeutic applications
02/18/2010US20100041141 Methods and compositions relating to improved lentiviral vectors and their applications
02/18/2010US20100041022 Novel assay for the separation and quantification of hemagglutinin antigens
02/18/2010US20100040649 Inducible expression systems
02/18/2010US20100040580 Freeze-dried composition of inactivated virus envelope with membrane fusion activity
02/18/2010CA2733399A1 Compositions and methods for the production of alpha-herpesviruses
02/17/2010EP2154149A1 A truncated l1 protein of human papillomavirus 6
02/17/2010EP2154148A1 A truncated l1 protein of human papillomavirus 11
02/17/2010EP2154147A1 A truncated l1 protein of human papillomavirus 16
02/17/2010EP2154146A1 Use of african swine pest haemoglutinin as an adjuvant
02/17/2010EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule
02/17/2010EP2152863A1 Human parainfluenza viruses having separated p and c genes
02/17/2010EP1578919B1 Endogenous retrovirus up-regulated in prostate cancer
02/17/2010EP1404816B1 Human hepatoma cell lines, methods for obtaining same and uses thereof
02/17/2010EP1240186B1 Improvements in or relating to immune responses to hiv
02/16/2010US7662939 Molecular determinants of tropism and virulence in enteroviruses
02/16/2010US7662916 Modified HIV Env polypeptides
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 267